India Markets close in 2 hrs 50 mins

Knight Therapeutics Inc. (GUD.TO)

Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
5.86-0.04 (-0.68%)
At close: 3:12PM EDT
Currency in CAD

Valuation measures

Market cap (intra-day) 5767.3M
Enterprise value 3374.61M
Trailing P/E 142.93
Forward P/E 158.60
PEG Ratio (5 yr expected) 11,039.25
Price/sales (ttm)5.47
Price/book (mrq)0.97
Enterprise value/revenue 32.67
Enterprise value/EBITDA 656.67

Trading information

Stock price history

Beta (5Y monthly) 0.76
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 38.88
52-week low 34.73
50-day moving average 36.25
200-day moving average 36.81

Share statistics

Avg vol (3-month) 3218.28k
Avg vol (10-day) 3188.87k
Shares outstanding 5130.94M
Float 98.26M
% held by insiders 124.69%
% held by institutions 120.61%
Shares short (14-Sep-2020) 43.89M
Short ratio (14-Sep-2020) 419.51
Short % of float (14-Sep-2020) 4N/A
Short % of shares outstanding (14-Sep-2020) 42.97%
Shares short (prior month 13-Aug-2020) 43.93M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30-Dec-2019
Most-recent quarter (mrq)29-Jun-2020

Profitability

Profit margin 4.35%
Operating margin (ttm)-8.16%

Management effectiveness

Return on assets (ttm)-0.62%
Return on equity (ttm)-0.01%

Income statement

Revenue (ttm)140.39M
Revenue per share (ttm)1.04
Quarterly revenue growth (yoy)1,562.00%
Gross profit (ttm)26.92M
EBITDA 6.61M
Net income avi to common (ttm)6.11M
Diluted EPS (ttm)0.04
Quarterly earnings growth (yoy)-8.00%

Balance sheet

Total cash (mrq)536.35M
Total cash per share (mrq)4.1
Total debt (mrq)51.29M
Total debt/equity (mrq)5.84
Current ratio (mrq)2.31
Book value per share (mrq)6.05

Cash flow statement

Operating cash flow (ttm)-1.56M
Levered free cash flow (ttm)77.48M